A raft of lawsuits centered in New Jersey allege that Schering-Plough Corp. offered bribes, kickbacks and other incentives to doctors to get them to prescribe its hepatitis and cancer drugs for uses not approved by the Food and Drug Administration.

Of six lawsuits filed, five are pending with U.S. District Judge Stanley Chesler in Newark, N.J., and the Kenilworth, N.J., drug company wants the cases tried in that state.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]